CYP2C19基因多态性与氯吡格雷ADP抑制率的关系(4)
[9] Lin XB，Li ZW，Yan M，et al. Population pharmacokinetics of Voriconazole and CYP2C19 polymorphisms for optimizing dosing regimens in renal transplant recipients [J]. Br J Clin Pharmacol，2018，84(7)：46-49.[10] Hariharan S，Southworth MR，Madabushi R. Clopidogrel，CYP2C19 and proton pump inhibitors：what we know and what it means [J]. J Clin Pharmacol ......
您现在查看是摘要页，全文长 2651 字符。